5-(4-acetamidophenyl)pyrazin-2(1h)-one has been researched along with 8-bromoguanosino-3',5'-cyclic monophosphorothioate in 1 studies
| Studies (5-(4-acetamidophenyl)pyrazin-2(1h)-one) | Trials (5-(4-acetamidophenyl)pyrazin-2(1h)-one) | Recent Studies (post-2010) (5-(4-acetamidophenyl)pyrazin-2(1h)-one) | Studies (8-bromoguanosino-3',5'-cyclic monophosphorothioate) | Trials (8-bromoguanosino-3',5'-cyclic monophosphorothioate) | Recent Studies (post-2010) (8-bromoguanosino-3',5'-cyclic monophosphorothioate) |
|---|---|---|---|---|---|
| 38 | 0 | 0 | 90 | 0 | 27 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eckly-Michel, A; Lugnier, C; Martin, V | 1 |
1 other study(ies) available for 5-(4-acetamidophenyl)pyrazin-2(1h)-one and 8-bromoguanosino-3',5'-cyclic monophosphorothioate
| Article | Year |
|---|---|
Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation.
Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Animals; Aorta; Calcium; Cardiotonic Agents; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Isoproterenol; Isoquinolines; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Pyrazines; Pyrrolidinones; Rats; Rats, Wistar; Rolipram; Signal Transduction; Sulfonamides; Thionucleotides | 1997 |